MAPK6 and breast carcinoma: The expression of ERK3 is known to be upregulated in several human cancers: Non‐small‐cell lung carcinoma (NSCLC) [31, 34, 35, 39], breast cancer [40], gastric cancer [41] and melanoma [42, 43].